Overview

Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food

Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This trial will study the tolerability and pharmacokinetic of fexinidazole using two different dosage regimen of repeated administrations. The drug is administered to human healthy volunteers of sub-saharan origin together with food, once a day during 10 days, with a loading dose during 4 days.
Phase:
Phase 1
Details
Lead Sponsor:
Drugs for Neglected Diseases